Thromb Haemost 1978; 39(01): 046-052
DOI: 10.1055/s-0038-1646653
Original Article
Schattauer GmbH Stuttgart

The Effects of Metal Ions on Esterase Activities of Urokinase

Hiroyuki Sumi
The 2nd Department of Physiology, Hamamatsu University, School of Medicine, Hamamatsu, Shizuoka, Japan
,
Yumiko Takada
The 2nd Department of Physiology, Hamamatsu University, School of Medicine, Hamamatsu, Shizuoka, Japan
,
Akikazu Takada
The 2nd Department of Physiology, Hamamatsu University, School of Medicine, Hamamatsu, Shizuoka, Japan
› Author Affiliations
Further Information

Publication History

Received 06 March 1997

Accepted 20 June 1997

Publication Date:
12 July 2018 (online)

Summary

The esterase activity of highly purified human urokinase on Nα-acetylglycyl-L-lysine methyl ester is strongly inhibited by 1 × 10-5tol × 10“2MCu++, Hg++, Ni++, Co++, Fe+++, and Mn++ solutions, whereas Na+, K+, Ca++, and Mg++ are weakly effective. This inhibition is parallel with the inhibition of activation of plasminogen by urokinase. There is no simple linear relation between inhibition and ion concentration. Addition of ethylenediaminetetraacetate or electrodialysis fully reactivates the inhibited enzyme. These results are discussed in relation to similar effects of ions on trypsin.

 
  • References

  • 1 Astrup T, Sterndorff I. 1952; An activator of plasminogen in normal urine. Proceeding of the Society for Experimental Biology and Medicine 81: 675
  • 2 Åstedt B, Holmberg L. 1976; Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture. Nature 261: 595
  • 3 Bennett NB. 1967; A method for the quantitative assay of inhibitor of plasminogen activation in human serum. Thrombosis et Diathesis Haemorrhagica 17: 12
  • 4 Green MM, Neurath H. 1953; The effects of divalent cations on trypsin. Journal of Biological Chemistry 204: 379
  • 5 Johnson AJ, Kline DL, Alkjaersig N. 1969; Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems. Thrombosis et Diathesis Haemorrhagica 21: 259
  • 6 Kjeldgaard NO, Ploug J. 1957; Urokinase: An activator of plasminogen from human urine. II. Mechanism of plasminogen activation. Biochimica et Biophysica Acta 24: 283
  • 7 Lesuk L, Terminiello L, Traver JH. 1965; Crystalline human urokinase: some properties. Science 147: 880
  • 8 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265
  • 9 Muramatu M, Fujii S. 1968; Inhibitory effects of ω-guanidino acid esters on trypsin, plasmin, thrombin and plasma kallikrein. Journal of Biochemistry 64: 807
  • 10 Ploug JO, Kjeldgaard NO. 1957; Urokinase: An activator of plasminogen from human urine. I. Isolation and properties. Biochimica et Biophysica Acta 24: 278
  • 11 Roberts RS. 1958; Measurement of the rate of plasmin action on synthetic substrates. Journal of Biological Chemistry 232: 285
  • 12 Sobel GW, Mohler SR, Jones NW, Dawely ABC, Guest MM. 1952; Urokinase: An activator of plasma profibrinolysin extracted from urine. American Journal of Physiology 171: 768
  • 13 Soberano ME, Ong EB, Johnson AJ, Schoellmann S, Levy M. 1975; Inhibition studies of urokinase with diisopropylphosphorofluoridate (DFP) and p-nitrophenyl-p’-guanidinobenzoate (NPGB). Federation Proceedings 34: 860
  • 14 Walton PL. 1967; The hydrolysis of α-N-acetylglycyl-L-lysine methyl ester by urokinase. Biochimica et Biophysica Acta 132: 104
  • 15 White WT, Barlow GH, Mozen HM. 1966; The isolation and characterization of plasminogen activator (urokinase) from human urine. Biochemistry 5: 2160
  • 16 Williams JRB. 1951; The fibrinolytic activity of urine. British Journal of Experimental Pathology 32: 530